So CMS cuts reimbursement for fluorescein angiography by 50%, and Akorn
increases the price of fluorescein by 10% per vial.
Who's running Akorn now, Martin Shkreli?
Darrin A Landry, CRA, OCT-C
Ophthalmic Consultant
Bryson Taylor, Inc.
207-838-0961
www.brysontaylor.com